Using magnetic stimulation to help people quit smoking
Official title: A Pragmatic Feasibility Trial on the Implementation of Transcranial Magnetic Stimulation for Smoking Cessation
Run by Centre for Addiction and Mental Health · NCT06346028 · Data updated 2026-11-12
This study is testing if a new type of brain stimulation can help daily smokers quit smoking by making it easier for them to stop.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Centre for Addiction and Mental Health Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | March 30, 2024 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | March 27, 2026 |
| Trial ID | NCT06346028 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are daily smokers who are seeking assistance to quit smoking.
✕Probably not a fit
Patients with certain medical conditions, such as a history of seizures or those with intracranial implants, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the use of repetitive transcranial magnetic stimulation (rTMS) as a non-invasive treatment to assist daily smokers in quitting. Participants will undergo a treatment course consisting of daily rTMS sessions for three weeks, followed by weekly sessions for an additional three weeks. The study aims to assess the feasibility of implementing rTMS in the Nicotine Dependence Clinic at the Center for Addiction and Mental Health in Toronto, Canada, while also gathering participant feedback through surveys and interviews.
Why it matters
Potential benefit: If successful, this treatment could provide a new, effective option for individuals struggling to quit smoking.
How similar studies have gone: Previous studies have shown success with rTMS for smoking cessation, indicating a promising approach to treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients receiving rTMS * Smoking cigarettes daily (self-reported) Inclusion Criteria: Health care providers * Currently employed as a HCP (physician, social worker, occupational therapist, etc.) at the CAMH NDC * Involved in the care of at least 1 patient who has received rTMS for smoking cessation Exclusion Criteria: Patients receiving rTMS * Have any intracranial implant (e.g., aneurysm clips) or any other metal object within or near the head, excluding the mouth, that cannot be safely removed. * Pregnant or intending to be pregnant during the study. * A history of a primary seizure disorder, seizure associated with an intracranial lesion, recurrent seizures related to substance intoxication or withdrawal or recent seizure within the last 6 months. * Taking any anticonvulsant medication unless it cannot be tapered or discontinued due to risk of clinical safety or destabilization, according to the participant or their referring physician. * Taking benzodiazepines with dose equivalent or greater than lorazepam 2mg/day unless it cannot be tapered or discontinued due to risk of clinical safety or destabilization, according to the participant or their referring physician. * Space occupying intracranial lesion. * Acutely unstable medical, psychiatric, or substance use disorder comorbidity with safety concerns at the discretion of the PI or study physician. Exclusion Criteria: Health care providers \- There are no exclusion criteria for HCP Participants
Where it's running
-
Center for Addiction and Mental Health (CAMH)
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Victor Tang, MD, MSc — Center for Addiction and Mental Health
- Study coordinator: Alexandra S, BScH
- Email: rtms.smoking@camh.ca
- Phone: 416-535-8501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers
This study tests whether salivary IL-8 and blood IL-6 can help tell apart adults with oral premalignant conditions from those with healthy mouths, and whether smoking influences these markers.
-
Access to multiple tobacco flavors to help adult cigarette smokers quit using e-cigarettes
This study tests whether giving adult smokers an e-cigarette with a choice of flavors helps them quit smoking by the end of 13 weeks.
-
Smoking, MFN1, and NLRP3 Levels in Gum Fluid Across Periodontal Health and Disease
This study tests whether smoking changes MFN1 and NLRP3 protein levels in the fluid around the gums for adults with or without periodontitis.
-
Heated tobacco access and cigarette quitting among adult smokers
This study tests whether giving adult smokers access to a heated tobacco product helps them quit smoking by the end of 3 months.
-
How flavors of ENDS might help adults quit smoking their usual cigarettes
This study tests whether giving adults who smoke their regular cigarettes an electronic nicotine delivery system with different flavors can help them quit smoking their usual cigarettes after 3 months.
-
Comparing chest PNF and chest mobility exercises for university students who smoke
This trial tries two chest exercise programs to see if they help 18–24-year-old university students who smoke breathe better and improve lung function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.